Sorrento Therapeutics, Inc. (NASDAQ:SRNE – Get Free Report) shares passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.01 and traded as high as $0.01. Sorrento Therapeutics shares last traded at $0.0026, with a volume of 208,761 shares trading hands.
Sorrento Therapeutics Stock Performance
The company has a market capitalization of $1.43 million, a price-to-earnings ratio of 0.00 and a beta of 1.23. The firm has a fifty day moving average price of $0.01.
Sorrento Therapeutics Company Profile
Sorrento Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the development of therapies in immuno-oncology, inflammatory diseases and pain management. Leveraging proprietary antibody, small molecule and cell therapy platforms, Sorrento aims to advance next-generation treatment candidates that address unmet medical needs in oncology and chronic pain without reliance on traditional opioids.
The company’s immuno-oncology pipeline encompasses monoclonal antibodies, antibody-drug conjugates and engineered cell therapies designed to target solid tumors and hematologic malignancies.
Further Reading
- Five stocks we like better than Sorrento Therapeutics
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- Punch these codes into your ordinary brokerage account
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
